Life Science REIT PLC
LSE:LABS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
31.5
65.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Life Science REIT PLC
Cash Paid for Dividends
Life Science REIT PLC
Cash Paid for Dividends Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Paid for Dividends | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Life Science REIT PLC
LSE:LABS
|
Cash Paid for Dividends
-£14m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Primary Health Properties PLC
LSE:PHP
|
Cash Paid for Dividends
-£90.8m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-17%
|
|
|
Assura PLC
LSE:AGR
|
Cash Paid for Dividends
-£90.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Target Healthcare REIT PLC
LSE:THRL
|
Cash Paid for Dividends
-£36.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Impact Healthcare REIT PLC
LSE:IHR
|
Cash Paid for Dividends
-£28.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Life Science REIT PLC
Glance View
Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. The Company’s investment objective is to provide shareholders with a level of total return. The company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the United Kingdom which are leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. The company acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. The company acquires individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in, or providing a benefit to, the life science sector. The Company’s investment adviser is Ironstone Asset Management Limited.
See Also
What is Life Science REIT PLC's Cash Paid for Dividends?
Cash Paid for Dividends
-14m
GBP
Based on the financial report for Dec 31, 2023, Life Science REIT PLC's Cash Paid for Dividends amounts to -14m GBP.
What is Life Science REIT PLC's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 1Y
-300%
Over the last year, the Cash Paid for Dividends growth was -300%.
You don't have any saved screeners yet
